News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer – NCI Center for Cancer Research
Nirali Shah/npr.org
Apr 22, 2025, 11:06

How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer – NCI Center for Cancer Research

NCI Center for Cancer Research shared a post on LinkedIn:

“CD22 CAR T-cell immunotherapy is an effective treatment for several types of cancer, with a recent clinical trial showing a 70% response rate.

Researchers wanted to know more about why 30% of patients’ cancers didn’t respond: the answer may lie in the baseline condition of their immune cells. Read more about this CCR study, led by Nirali Shah, from our Pediatric Oncology Branch.

Learn more about research in our Pediatric Oncology Branch.

Image: Microscopy image of B-cell acute lymphoblastic leukemia.

Credit: iStock.”

How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer - NCI Center for Cancer Research

cancer CAR T-CELL CD22 fight against cancer Global fight against cancer immunotherapy NCI Center for Cancer Research Nirali Shah OncoDaily Oncology pediatric oncology
Special Coverage
Blog
Jun 4, 2025, 00:35
Ruben Mesa: Important work in Pharmacogenomics around DPYD at ASCO25
Blog
Jun 4, 2025, 00:12
Dinesh Raj Neupane: Paying the Price for Distance: Travel-Driven Financial Toxicity Among Cancer Patients in Nepal
Blog
Jun 3, 2025, 20:49
Tracey O’Brien: Excited to Announce Speakers for the Inaugural NSW Cancer Summit 2025
Insight
Jun 3, 2025, 18:29
Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC
Insight
Jun 3, 2025, 18:25
From Political Will to Global Wake-Up Call: Hesham ElGhazaly on Egypt’s National Cancer Strategy at ASCO 2025
Insight
Jun 3, 2025, 18:19
Clifford Hudis and Thomas Kurian Discussed AI in Oncology and ASCO Guidelines Assistant at ASCO 2025
Insight
Jun 3, 2025, 18:18
Elizabeth McKenna: Study on Vascular Normalization and Enhanced Immunotherapy
Insight
Jun 3, 2025, 17:25
Mohammad Jad Moussa: Huge Congrats to My Future Co-Resident Sam Black on This ASCO 2025 Feat
Insight
Jun 3, 2025, 17:21
Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025
Insight
Jun 3, 2025, 16:58
Paolo Tarantino Presented DATO-Base Trial Poster at ASCO 2025 on Breast Cancer CNS Metastases
Insight
Jun 3, 2025, 16:39
Pashtoon Kasi: This Is the 1st Time I Started Hearing the Word “CURE” in Patients with Metastatic Stage-IV Cancers
Blog
Jun 3, 2025, 16:39
Massimo Di Maio: Standing Ovation for CHALLENGE phase 3 trial at ASCO25